by Genalyte | Jul 22, 2024 | News
San Diego, CA — July 22, 2024 — Genalyte announces that it has received the first U.S. Food and Drug Administration (FDA) clearance for a Thyroid Stimulating Hormone (TSH) Immunoassay performed on a silicon chip. The FDA clearance for this assay is a significant...
by 360Dx - Adam Bonislawski | Sep 20, 2023 | 360DX, News
NEW YORK – Some five years after the collapse of Theranos, a handful of diagnostic companies are once again trying to bring routine clinical testing to the point of care… Read the full article here.
by Genalyte | Apr 21, 2023 | News
San Diego, CA– Genalyte, Inc., a leading diagnostics and analytics company, announced that it has closed on the expansion of its Series C financing to include an additional $17.5 million for a total of over $67 million, led by Verily Life Sciences (an Alphabet...
by FortuneBusinessInsights | Aug 11, 2022 | Fortune, News
According to Fortune Business Insights, the global Blood Group Typing Market size is projected to reach USD 2.68 Billion by 2027, at CAGR of 7.2% during forecast period; Fears Arising from Covid-19 Pandemic to Severely Affect Blood Collection Globally Pune, India,...
by Joe Panetta | Jul 28, 2022 | News, San Diego Union Tribune
BY JOE PANETTA, MIKE GUERRA, MICHELLE MCMURRY-HEATH JUNE 7, 2022 6 AM PT Read the full article here.
by Business Wire | May 9, 2022 | Business Wire, News
DUBLIN–(BUSINESS WIRE)–The “Future Unicorns in Healthtech” report has been added to ResearchAndMarkets.com’s offering. To read the full report, click here.
Recent Comments